IG Technology

Legacy is clinically shown to prevent blood clots, the #1 preventable cause of deaths in our hospitals.

IG Technology Ltd specialises in the design and manufacture of medical devices, focusing on the prevention of venous thromboembolism (VTE). Their flagship product, the Legacy Intermittent Pneumatic Compression (IPC) device, is a lightweight, portable solution that enhances blood circulation to reduce the risk of blood clots. The device features integrated wireless connectivity for seamless monitoring and control, and is complemented by a user-friendly mobile application that provides real-time data and treatment reminders. This innovative approach ensures effective blood clot prevention both in hospitals and at home where we have started with US Care at Home programs that allows for reimbursement.

Legacy is approved in the US, Middle East and South Asia with contracts awarded from various health providers. IG Technology were awarded the Mayo Clinic Start Up 2025 and the Vizient Innovative Technology 2024 and 2025. The company is ISO13485 approved for design and manufacture of medical devices.